Characterization by LC-MS/MS of two conjugate vaccines using KLH as carrier protein

Satomy Pousa,Pablo E. Ramos-Bermúdez,Vladimir Besada,Ania Cabrales-Rico,Hilda Elisa Garay,Alina Rodríguez-Mallón,Katharina Zettl,Jacek R Wiśniewski,Luis Javier González
DOI: https://doi.org/10.26434/chemrxiv-2024-nslhn
2024-09-03
Abstract:Keyhole limpet haemocyanins (KLH1 and KLH2) from Megathura crenulata, are large ( 3900 amino acids) multi-subunit oxygen-carrying metalloproteins, that are widely used as carrier proteins in conjugate vaccines and in immunotherapy. KLHs and their derived conjugate vaccines are poorly characterized by mass spectrometry due to the very stable supramolecular structures with megadalton molecular mass, and the resistance to be efficiently digested with standard protocols using specific proteases. KLH1 and KLH2 proteins were conjugated to the conserved twenty-one amino acids pP0 peptide, derived from the P0 acidic ribosomal protein of Rhipicephalus sp. ticks by using the maleimide-thiol chemistry. The resultant KLH1- and KLH2-Cys1pP0 conjugate vaccines were efficiently digested using the MED-FASP procedure, and analyzed by LC-MS/MS allowing approximately 85% sequence coverage of both conjugates. New PTMs not described for the KLH such as oxidized species were identified. The conjugation sites and Cys-His thioether bonds were determined by identifying cross-linked peptides using software developed for cross-linking mass spectrometry experiments. Conjugation sites were validated by combining sequence coverage, the presence of diagnostic and linker fragment ions in the MS/MS spectra, and the multi-peak pattern in the extracted ion chromatograms. In summary, 124 out of 170 Lys (75%) and 99 out 150 Lys (66%) were found conjugated to Cys1pP0 in KLH1 and KLH2, respectively. In total, four and seven Cys-His thioether bonds were experimentally determined in KLH1 and KLH2, respectively. This is the first report of the conjugation sites identification of two KLH-based vaccines determined by mass spectrometry
Chemistry
What problem does this paper attempt to address?
The paper aims to address the following issues: 1. **Characterization of KLH (Keyhole Limpet Hemocyanin) as a carrier protein in conjugate vaccines**: The paper studied two conjugate vaccines using KLH as the carrier protein (KLH1-Cys1pP0 and KLH2-Cys1pP0) and performed detailed characterization of these conjugate vaccines using liquid chromatography-tandem mass spectrometry (LC-MS/MS). 2. **Identification of conjugation sites**: By digesting and analyzing the conjugate vaccines with mass spectrometry, the conjugation sites between KLH and the Cys1pP0 peptide were determined. Specifically, it was identified that 75% of lysines (170 out of 124) in KLH1 and 66% of lysines (150 out of 99) in KLH2 were conjugated with the Cys1pP0 peptide. 3. **Identification of new post-translational modifications (PTMs)**: Some new post-translational modifications in KLH were discovered, such as oxidized species (e.g., hydroxylation, dihydroxylation, etc.). Additionally, other types of oxidative modifications like tyrosine nitration were also detected. 4. **Validation of KLH sequence and amino acid changes**: Through mass spectrometry analysis of KLH1 and KLH2, the primary structure of the proteins was validated, and multiple amino acid changes were found, which helps in a more comprehensive understanding of the true sequences of these two proteins. 5. **Identification of Cys-His thioether bonds**: Multiple Cys-His thioether bonds were identified for the first time in KLH1 and KLH2, which are crucial for the protein's function. In summary, the paper mainly addresses how to use mass spectrometry techniques to thoroughly characterize KLH as a carrier protein in conjugate vaccines, identifying its conjugation sites, new post-translational modifications, and important structural features. These findings contribute to the further development of efficient and well-characterized biotechnological products based on KLH.